The Food and Drug Administration has conducted a study into the drospirenone-containing birth control pills, Yasmin and Yaz and found that these birth controls have a 75 percent higher risk of causing blood clots.
The report about the drug’s safety was released last week and stated that results from the study show that the birth control pill increases a woman’s risk of developing a blood clot. This study was released just weeks before the FDA will meet with a committee about Yasmin and Yaz.
The FDA’s study looked into 800,000 women between the years 2001 and 2007 and it found that the women who used the drospirenone-containing oral contraceptives faced a 75 percent higher risk of developing a blood clot and that symptoms were usually seen within three months of starting the pill.
If you or a loved one has developed a blood clot after using Yasmin or Yaz birth control, you need experienced representation on your side. Contact the Yasmin lawsuit lawyers of Williams Kherkher by calling 800-761-3187 today.